Voyager Therapeutics (VYGR) EBT Margin: 2015-2025
Historic EBT Margin for Voyager Therapeutics (VYGR) over the last 11 years, with Sep 2025 value amounting to -207.53%.
- Voyager Therapeutics' EBT Margin fell 17098.00% to -207.53% in Q3 2025 from the same period last year, while for Sep 2025 it was -401.76%, marking a year-over-year decrease of 41811.00%. This contributed to the annual value of -80.42% for FY2024, which is 13391.00% down from last year.
- Latest data reveals that Voyager Therapeutics reported EBT Margin of -207.53% as of Q3 2025, which was up 67.66% from -641.67% recorded in Q2 2025.
- Voyager Therapeutics' 5-year EBT Margin high stood at 1,523.23% for Q4 2022, and its period low was -3,239.97% during Q1 2022.
- Its 3-year average for EBT Margin is -260.49%, with a median of -207.53% in 2025.
- Per our database at Business Quant, Voyager Therapeutics' EBT Margin slumped by 284,665bps in 2022 and then skyrocketed by 332,287bps in 2023.
- Voyager Therapeutics' EBT Margin (Quarterly) stood at 18.02% in 2021, then skyrocketed by 150,520bps to 1,523.23% in 2022, then tumbled by 145,969bps to 63.53% in 2023, then plummeted by 60,356bps to -540.03% in 2024, then slumped by 17,098bps to -207.53% in 2025.
- Its EBT Margin was -207.53% in Q3 2025, compared to -641.67% in Q2 2025 and -476.68% in Q1 2025.